Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatocellular carcinoma.

Jorge A Marrero1

  • 1Department of Internal Medicine, Division of Gastroenterology, University of Michigan Medical Center, Ann Arbor, 48109, USA.

Current Opinion in Gastroenterology
|April 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AGA Clinical Practice Update on Risk Stratification and Emerging Surveillance Strategies for Hepatocellular Carcinoma: Expert Review.

Gastroenterology·2026
Same author

Validation of Texas Hepatocellular Carcinoma Consortium Risk Index in the Hepatocellular Carcinoma Early Detection Strategy Study.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Shifts in Cohort Eligibility With Deimplementation of Race-specific Guidance for Hepatocellular Carcinoma Surveillance.

Gastro hep advances·2025
Same author

HES V2.0 validation and performance compared to GALAD and ASAP in the HEDS cohort.

Journal of hepatology·2025
Same author

Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel.

Hepatology (Baltimore, Md.)·2025
Same author

AI-based phenotyping of hepatic fiber morphology to inform molecular alterations in metabolic dysfunction-associated steatotic liver disease.

Hepatology (Baltimore, Md.)·2025
Same journal

Endoscopic techniques to minimize gastroesophageal reflux during peroral endoscopic myotomy.

Current opinion in gastroenterology·2026
Same journal

Postendoscopy esophageal adenocarcinoma and neoplasia: current status and future directions.

Current opinion in gastroenterology·2026
Same journal

The complement system in inflammatory bowel disease: from early observations to emerging frontiers.

Current opinion in gastroenterology·2026
Same journal

Goblet cell-associated antigen passages in health and disease.

Current opinion in gastroenterology·2026
Same journal

Inflammatory bowel diseases 2026: form, function and therapeutic considerations for the epithelial barrier.

Current opinion in gastroenterology·2026
Same journal

Dietary protein as a regulator of colitis and colorectal cancer.

Current opinion in gastroenterology·2026
See all related articles

Hepatocellular carcinoma (HCC) risk factors like obesity and viral infections interact in cirrhosis patients. Tailored surveillance for high-risk individuals and standardized diagnostic criteria, including lesion washout, are crucial for better HCC care.

Area of Science:

  • Hepatology
  • Oncology
  • Gastroenterology

Background:

  • Hepatocellular carcinoma (HCC) incidence is rising globally.
  • Risk factors and diagnostic criteria for HCC require further clarification.
  • Cirrhosis is a major precursor to HCC development.

Purpose of the Study:

  • To review current knowledge on HCC risk factors.
  • To evaluate surveillance strategies for HCC in cirrhotic patients.
  • To discuss standardized diagnostic criteria for HCC.

Main Methods:

  • Literature review of recent studies on HCC.
  • Analysis of risk factor interactions (alcohol, obesity, viral etiology).
  • Evaluation of surveillance cost-effectiveness and diagnostic accuracy.

Related Experiment Videos

Main Results:

  • Interactions of alcohol, tobacco, obesity, diabetes, and viral etiology increase HCC risk in cirrhosis.
  • Surveillance of cirrhotic patients improves survival and is cost-effective.
  • Imaging can understage HCC; lesion washout is a sensitive and specific diagnostic criterion.

Conclusions:

  • Risk stratification is needed to tailor HCC surveillance in cirrhosis.
  • Standardized diagnostic criteria are essential for HCC patient care and research.
  • Arterially enhancing lesion washout should be a key diagnostic criterion for HCC.